Epidemiological profile of women with breast cancer treated at an oncology specialty clinic in southern Brazil
DOI:
https://doi.org/10.29289/2594539420250062Palavras-chave:
breast neoplasms, breast cancer, delayed diagnosis, lymph nodes, neoplasm metastasisResumo
Introduction: Breast cancer is the most common cancer in women, with increasing incidence and proportionally higher mortality in low- and middle-income countries. Delays in diagnosis and treatment are associated with worse outcomes. Objective: To analyze the epidemiological profile of women with breast cancer treated at an oncology clinic in the southern region of the state of Santa Catarina, in 2022. Methods: This is a cross-sectional study with 422 patients ≥18 years old, diagnosed with malignant breast neoplasm. Medical record data included age, laterality, histological type, time between diagnosis and surgery, lymph node involvement, metastasis, and treatment. Statistical analyses were performed using SPSS 20.0, with the significance level set at 5% (p<0.05). Results: The mean age was 51.5 years, with a predominance of the 40–59 age group (56.6%) and incidence in the left breast (52.1%). Invasive breast carcinoma and subtypes accounted for 98.8% of cases, with emphasis on those unspecified (47.4%) and human epidermal growth factor receptor 2–positive (HER2+; 25.8%). The median time between diagnosis and surgery was 5.2 months (interquartile range: 2.3–8.1). Affected lymph nodes were associated with longer time to surgery and increased risk of metastasis (odds ratio: 42.30; 95% confidence interval: 10.05–178.02). All patients underwent surgery, with 363 (86.0%) receiving chemotherapy, radiotherapy, and surgery associated with new therapies (CT + RT + surgery + novel therapies). Other treatments included CT + surgery (10.2%), RT + surgery (1.7%), and surgery alone (2.1%). Conclusion: A predominance of invasive carcinomas was observed, with diagnosis occurring during productive age, and significant delays in access to surgical treatment. A strong association between positive lymph nodes and metastasis was identified. The significant proportion of patients with access to new therapies reflects the incorporation of oncological advances in the regional public health service, although the observed delays highlight the need to optimize care flows.
Downloads
Referências
1. Shang C, Xu D. Epidemiology of breast cancer. Oncologie. 2022;24(4):649-63. https://doi.org/10.32604/oncologie.2022.027640
2. Anton S, Lazan A, Grigore M, Ilea C, Scripcariu S-I, Popa S, et al. Current trends in breast cancer genetics, risk factors, and screening strategies. J Biol Methods. 2025;12(2):e99010054. https://doi.org/10.14440/jbm.2025.0079
3. Handa LYS, Paiva LS, Sousa LVA. Análise epidemiológica dos protocolos de rastreamento e tratamento do câncer de mama no contexto brasileiro. Clin Oncol Let. 2025;5(1):e2025001. http://doi.org/10.4322/col.2025.001
4. Cecilio AP, Takakura ET, Jumes JJ, dos Santos JW, Herrera AC, Victorino VJ, et al. Breast cancer in Brazil: epidemiology and treatment challenges. Breast Cancer (Dove Med Press). 2015;7:43–9. https://doi.org/10.2147/bctt.s50361
5. Łukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R, Stanislawek A. Breast cancer – epidemiology, risk factors, classification, prognostic markers, and current treatment strategies. Cancers (Basel). 2021;13(17):4287. https://doi.org/10.3390/cancers13174287
6. Roheel A, Khan A, Anwar F, Akbar Z, Akhtar MF, Khan MI, et al. Global epidemiology of breast cancer based on risk factors: a systematic review. Front Oncol. 2023;13:1270473. https://doi.org/10.3389/fonc.2023.1240098
7. Terry MB, Colditz GA. Epidemiology and risk factors for breast cancer: 21st century advances. Cold Spring Harb Perspect Med. 2023;13(9):a041317. https://doi.org/10.1101/cshperspect.a041317
8. Winters S, Martin C, Murphy D, Shokar NK. Breast cancer epidemiology, prevention, and screening. Prog Mol Biol Transl Sci. 2017;151:1-32. https://doi.org/10.1016/bs.pmbts.2017.07.002
9. Nascimento RG. Epidemiology and risk factors for breast cancer: a literature review. Rev Cient Multidiscip Núcleo Conhecimento. 2022;6(9):5-17. https://doi.org/10.32749/nucleodoconhecimento.com.br/health/risk-factors
10. Roque B, Lima MEV, Bezerra RC, Santiago MB, Amorim CSV, da Costa RSL. Perfil epidemiológico e clínico de mulheres diagnosticadas com câncer de mama no Brasil. In: Marques NSF, da Costa RSL. Ciências Biológicas e da Saúde: Pesquisas Básicas e Aplicadas. Rio Branco: Stricto Sensu Editora; 2021. p. 198-212.
11. Evangelista GS, Dutra MC. Câncer de mama no Brasil – prevalência entre 2014 e 2023 e a importância da mamografia no rastreamento. Rev FT. 2024;29(3):1-15. https://doi.org/10.69849/revistaft/ni10202411301359
12. Luna ACM, Araújo AMM, Cardenas B, Moreira AL, Mendes IFL, Tizolim MR, et al. A epidemiologia do câncer de mama em Roraima. Braz J Health Rev. 2020;3(4):10570–82. https://doi.org/10.34119/bjhrv3n4-319
13. Cunha UMM, Lucena KDT, Sousa LVA. Pandemia da COVID-19 e seu reflexo no rastreamento do câncer de mama no Brasil. J Hum Growth Dev. 2024;34(2):328-41.
14. Smolarz B, Nowak AZ, Romanowicz H. Breast cancer – epidemiology, classification, pathogenesis and treatment. Cancers (Basel). 2022;14(10):2569. https://doi.org/10.3390/cancers14102569
15. Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, et al. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021;149(4):778- 89. https://doi.org/10.1002/ijc.33588
16. Abdou Y, Gupta M, Asaoka M, Attwood K, Mateusz O, Gandhi S, et al. Left sided breast cancer is associated with aggressive biology and worse outcomes than right sided breast cancer. Sci Rep. 2022;12(1):13377. https://doi.org/10.1038/s41598-022-16749-4
17. Moreira CN, Teixeira MLS, Domingues EM, da Silva CMF, Durães ATS, dos Santos VT, et al. Perfil clínico-epidemiológico e histológico do câncer de mama no estado da Bahia, no período entre 2011 e 2021. Braz J Health Rev. 2023;6(2):4711-25. https://doi.org/10.34119/bjhrv6n2-022
18. Ungvari Z, Fekete M, Buda A, Lehockzi A, Munkácsy G, Scaffidi P, et al. Quantifying the impact of treatment delays on breast cancer survival outcomes: a meta-analysis. Geroscience. 2026;48(1):1173-87. https://doi.org/10.1007/s11357-025-01719-1
19. de Lima DAN, Pelloso FC, Pereira ECA, Carvalho MDB, Camparoto CW, Ribeiro HF, et al. Delay in diagnosis and treatment of breast cancer: regional disparities. Cancers (Basel). 2025;17(22):3612. https://doi.org/10.3390/cancers17111892
20. Eriksson L, Bergh J, Humphreys K, Wärnberg F, Törnberg S, Czene K. Time from breast cancer diagnosis to therapeutic surgery and breast cancer prognosis: a population-based cohort study. Int J Cancer. 2018;143(5):1093-104. https://doi.org/10.1002/ijc.31411
21. Luo M, Lin X, Hao D, Shen KW, Wu W, Wang L, et al. Incidence and risk factors of lymph node metastasis in breast cancer patients without preoperative chemoradiotherapy and neoadjuvant therapy: analysis of SEER data. Gland Surg. 2023;12(11):1508-24. https://doi.org/10.21037/gs-23-258
22. Alvarenga CA, Santos M, Alvarenga M, Paravidino PI, Morais SS, Brenelli HB, et al. Localization of metastasis within the sentinel lymph node biopsies: a predictor of additional axillary spread of breast cancer? Rev Bras Ginecol Obstet. 2013;35(11):483-99. https://doi.org/10.1590/S0100-72032013001100002
23. Neves GJG, Quevedo AL, Lupi Júnior LA. Avanços na imunoterapia para câncer de mama triplo-negativo: eficácia, segurança e biomarcadores preditivos de resposta com anti-PD1 e anti-PDL1. Braz J Implantol Health Sci. 2024;6(9):2321-33. https://doi.org/10.36557/2674-8169.2024v6n9p2321-2333
24. Brasil. Câmara dos Deputados. Projeto de Lei nº 5514, de 2023. Dispõe sobre o acesso gratuito e universal à imunoterapia para pacientes com câncer e dá outras providências [Internet]. Brasília: Câmara dos Deputados; 2023 [cited on Nov. 10, 2025]. Available from: https://www.camara.leg.br/proposicoesWeb/fichadetramitacao?idProposicao=2403963
25. Ferreira APC. Não adesão ao tratamento: efeitos para a equipe e efeito da equipe [dissertação]. São Paulo: Faculdade de Psicologia, Universidade de São Paulo; 2017.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2026 Irismar da Silva Martins do Carmo, Michele Aparecida de Lima Maligeski Lemes, Kelser de Souza Kock
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
